Guzman y Gomez Shares Surge on Decision to Exit US Market and Refocus on Australia Bari Weiss Replaces 60 Minutes EP as Part of Shows Disruption CBS Hires Nick Bilton Forbes Reports Oil Prices Edge Higher Amid Skepticism Over USIran Negotiations UK Exports to US Slide 25 Following Trumps Tariff Measures Turning Trade Surplus into Deficit UK Spy Chief Warns of Moment of Consequence Geopolitical Risks Mount for Investors Micron Technology Crosses 1 Trillion Market Cap as AIDriven Memory Shortage Fuels 19 Stock Surge Enlight Renewable Energy Ltd Q1 2026 Earnings Positive EPS Performance Amidst Limited Data PYPD Q1 2026 Earnings EPS Beat on Operational Discipline But Revenue Remains Absent AEM Q1 2026 Earnings EPS Beat Drives 257 Stock Gain Amid Strong Gold Operations Kayne Anderson BDC Inc KBDC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response KPRX Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares CBFV Q1 2026 Earnings EPS Beats Estimates Stock Rises on Strong Performance Chaince Digital Holdings CD Surges Over 17 as Buyers Target Key Resistance Rain Enhancement Technologies RAIN Surges 649 Key Support and Resistance Levels in Focus Vertiv Holdings VRT Reaches 32746 After Modest Gain Nears Key Resistance Level Ramaco Resources Senior Notes METCZ Edge Higher in Quiet Session Bridgeline Digital BLIN Surges 2878 Breakout Attempt Nears Key Resistance Jaiprakash Power Ventures Surges 20 After Adani Power Acquires 24 Stake Medical Properties Trust Inc MPT Q1 2026 Earnings EPS Surges Past Estimates with 65 Beat JBK Holds Steady at 2622 as Support and Resistance Levels Come into Focus Innventure Inc Q1 2026 Earnings NarrowerThanExpected Loss Drives Mixed Market Reaction NFE Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rises 575 CVLT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response AVX Q1 2026 Earnings Loss Per Share and Stock Decline Highlight Challenges ACIW Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher TNYA Q1 2026 Earnings NarrowerThanExpected Loss Fails to Boost Shares as Revenue Remains Absent MDCX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Posts WiderthanExpected Loss